BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27166996)

  • 1. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.
    Tong D; Zhao L; He K; Sun H; Cai D; Ni L; Sun R; Chang S; Song T; Huang C
    Oncotarget; 2016 Jun; 7(23):34845-59. PubMed ID: 27166996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells.
    Qin Y; Zhao L; Wang X; Tong D; Hoover C; Wu F; Liu Y; Wang L; Liu L; Ni L; Song T; Huang C
    Glycobiology; 2017 Apr; 27(4):306-317. PubMed ID: 28100567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.
    Wang M; Qiu R; Gong Z; Zhao X; Wang T; Zhou L; Lu W; Shen B; Zhu W; Xu W
    J Cell Biochem; 2019 Sep; 120(9):15027-15037. PubMed ID: 31009138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.
    Zhao L; Liu Y; Tong D; Qin Y; Yang J; Xue M; Du N; Liu L; Guo B; Hou N; Han J; Liu S; Liu N; Zhao X; Wang L; Chen Y; Huang C
    EBioMedicine; 2017 Feb; 16():87-100. PubMed ID: 28131747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
    Wada R; Akiyama Y; Hashimoto Y; Fukamachi H; Yuasa Y
    Int J Cancer; 2010 Sep; 127(5):1106-14. PubMed ID: 20020497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
    Zhu F; Wu Q; Ni Z; Lei C; Li T; Shi Y
    Int J Mol Med; 2018 Jul; 42(1):228-236. PubMed ID: 29568890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00319 acts as a
    Zou J; Wu K; Lin C; Jie ZG
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2.
    Zhao H; Wen G; Huang Y; Yu X; Chen Q; Afzal TA; Luong le A; Zhu J; Ye S; Zhang L; Xiao Q
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):918-29. PubMed ID: 25722434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA NEAT1 promotes the growth of gastric cancer cells by regulating miR-497-5p/PIK3R1 axis.
    Xia TF; Chen J; Wu K; Zhang J; Yan Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6914-6926. PubMed ID: 31486491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3.
    Feng L; Cheng K; Zang R; Wang Q; Wang J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
    Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
    Zhang C; Zou Y; Dai DQ
    Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.
    Guo B; Cai S; Li W; Guo C; Liu Y; Ma X; Ma H; Zhao L
    Curr Cancer Drug Targets; 2022; 22(5):414-425. PubMed ID: 35209822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
    Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
    Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
    Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.